Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 3
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Ethical Aspects of Prodromal Synucleinopathy Prognostic Counseling.
Stefani A, Mozersky J, Kotagal V, Högl B, Ingravallo F, Ju YS, Avidan A, Sharp R, Videnovic A, Schenck CH, St Louis EK. Stefani A, et al. Semin Neurol. 2023 Feb;43(1):166-177. doi: 10.1055/a-2019-0245. Epub 2023 Jan 24. Semin Neurol. 2023. PMID: 36693433 Review.
Baseline characteristics of the North American prodromal Synucleinopathy cohort.
Elliott JE, Lim MM, Keil AT, Postuma RB, Pelletier A, Gagnon JF, St Louis EK, Forsberg LK, Fields JA, Huddleston DE, Bliwise DL, Avidan AY, Howell MJ, Schenck CH, McLeland J, Criswell SR, Videnovic A, During EH, Miglis MG, Shprecher DR, Lee-Iannotti JK, Boeve BF, Ju YS; North American Prodromal Synucleinopathy (NAPS) Consortium. Elliott JE, et al. Ann Clin Transl Neurol. 2023 Apr;10(4):520-535. doi: 10.1002/acn3.51738. Epub 2023 Feb 8. Ann Clin Transl Neurol. 2023. PMID: 36751940 Free PMC article. Clinical Trial.
Dementia with Lewy bodies: Impact of co-pathologies and implications for clinical trial design.
Toledo JB, Abdelnour C, Weil RS, Ferreira D, Rodriguez-Porcel F, Pilotto A, Wyman-Chick KA, Grothe MJ, Kane JPM, Taylor A, Rongve A, Scholz S, Leverenz JB, Boeve BF, Aarsland D, McKeith IG, Lewis S, Leroi I, Taylor JP; ISTAART Lewy body dementias Trial Methods Working Group. Toledo JB, et al. Alzheimers Dement. 2023 Jan;19(1):318-332. doi: 10.1002/alz.12814. Epub 2022 Oct 14. Alzheimers Dement. 2023. PMID: 36239924 Free PMC article. Review.
Lewy body dementia: Overcoming barriers and identifying solutions.
Agarwal K, Backler W, Bayram E, Bloom L, Boeve BF, Cha JH, Denslow M, Ferman TJ, Galasko D, Galvin JE, Gomperts SN, Irizarry MC, Kantarci K, Kaushik H, Kietlinski M, Koenig A, Leverenz JB, McKeith I, McLean PJ, Montine TJ, Moose SO, O'Brien JT, Panier V, Ramanathan S, Ringel MS, Scholz SW, Small J, Sperling RA, Taylor A, Taylor JP, Ward RA, Witten L, Hyman BT. Agarwal K, et al. Alzheimers Dement. 2024 Mar;20(3):2298-2308. doi: 10.1002/alz.13674. Epub 2024 Jan 24. Alzheimers Dement. 2024. PMID: 38265159 Free PMC article.
Role of GBA variants in Lewy body disease neuropathology.
Walton RL, Koga S, Beasley AI, White LJ, Griesacker T, Murray ME, Kasanuki K, Hou X, Fiesel FC, Springer W, Uitti RJ, Fields JA, Botha H, Ramanan VK, Kantarci K, Lowe VJ, Jack CR, Ertekin-Taner N, Savica R, Graff-Radford J, Petersen RC, Parisi JE, Reichard RR, Graff-Radford NR, Ferman TJ, Boeve BF, Wszolek ZK, Dickson DW, Ross OA, Heckman MG. Walton RL, et al. Acta Neuropathol. 2024 Mar 12;147(1):54. doi: 10.1007/s00401-024-02699-w. Acta Neuropathol. 2024. PMID: 38472443
20 results